Singapore markets open in 6 hours 39 minutes

Hisamitsu Pharmaceutical Co., Inc. (4530.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
3,636.00-28.00 (-0.76%)
At close: 03:15PM JST
Currency in JPY

Valuation measures4

Market cap (intra-day) 266.78B
Enterprise value 143.56B
Trailing P/E 20.04
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.98
Price/book (mrq)1.01
Enterprise value/revenue 1.01
Enterprise value/EBITDA 5.89

Trading information

Stock price history

Beta (5Y monthly) 0.39
52-week change 3-2.73%
S&P500 52-week change 326.24%
52-week high 35,497.00
52-week low 33,600.00
50-day moving average 33,762.54
200-day moving average 34,292.78

Share statistics

Avg vol (3-month) 3145.27k
Avg vol (10-day) 3135.25k
Shares outstanding 573.37M
Implied shares outstanding 676.48M
Float 854.49M
% held by insiders 122.30%
% held by institutions 130.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 486
Forward annual dividend yield 42.37%
Trailing annual dividend rate 385.00
Trailing annual dividend yield 32.32%
5-year average dividend yield 41.90
Payout ratio 446.85%
Dividend date 3N/A
Ex-dividend date 429 Aug 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 29 Feb 2024
Most-recent quarter (mrq)29 Feb 2024

Profitability

Profit margin 9.86%
Operating margin (ttm)2.31%

Management effectiveness

Return on assets (ttm)2.56%
Return on equity (ttm)5.49%

Income statement

Revenue (ttm)141.71B
Revenue per share (ttm)1,842.30
Quarterly revenue growth (yoy)6.70%
Gross profit (ttm)N/A
EBITDA 18.34B
Net income avi to common (ttm)13.97B
Diluted EPS (ttm)181.44
Quarterly earnings growth (yoy)-16.30%

Balance sheet

Total cash (mrq)125.32B
Total cash per share (mrq)1,654.55
Total debt (mrq)2.1B
Total debt/equity (mrq)0.79%
Current ratio (mrq)4.22
Book value per share (mrq)3,497.00

Cash flow statement

Operating cash flow (ttm)18.19B
Levered free cash flow (ttm)-2.7B